Desvenlafaxine Succinate
Pricing Report NDC 59762-1211-3

Latest NADAC: $0.37170 per EA · Effective Jul 17, 2024 · Est. package price $11.15 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Desvenlafaxine Succinate (NDC 59762-1211-3) is $0.37170 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 17, 2024.

As a provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.37170
Per EA

Effective Date
Jul 17, 2024
Billable Units
30 EA
Estimated Package Price
$11.15
Data Status
As of Aug 14, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.37170 to $1.47919 per EA. Over this 7 years and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3717 - $1.4792
Market Volatility
297.95% Variance
Latest Trend
25.53%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Jul 17, 2024 $0.37170 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $0.49915 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $0.40235 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $0.42618 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2024 $0.52485 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2024 $0.48020 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 17, 2024 $0.49668 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 20, 2023 $0.51161 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 22, 2023 $0.51678 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2023 $0.51879 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 20, 2023 $0.51733 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $0.46145 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026